A New Cancer Rehabilitation Process for Chemotherapy-Induced Foot Neuropathy Using Orthopedic Devices

Summary

The goal of this clinical study is to evaluate a new process for assessing and alleviating chemotherapy-induced peripheral neuropathy in the feet in patients treated with chemotherapy for early stage breast cancer. It will also compare two orthopedic interventions for symptom relief. The main questions it aims to answer are: Can an orthopedic silicone orthosis reduce chemotherapy-induced peripheral neuropathy symptoms in the feet? How does the effectiveness of the silicone orthosis compare to standard orthopedic treatment with insoles and shoes? Participants will: Use either a silicone orthosis or standard orthopedic treatment Have contact with the clinic for assessments and follow-ups Report their symptoms and functional improvements over time

Eligibility

Inclusion Criteria:

* Patients with breast cancer receiving treatment at the Oncology Department, Sahlgrenska University Hospital (SU).
* Have undergone treatment with taxanes.
* Aged 18 years or older.
* Able to understand spoken and written Swedish.
* Patients who can ambulate with or without assistive walking devices.
* CTCAE grading above 2 at a medical visit after completing treatment.

Exclusion Criteria:

* Bilateral amputation at the thigh level.
* Previously diagnosed neurological disease or neurological impairment affecting the feet.

Conditions3

Browse More Trials